PAX Labs Revenue, Valuation, Funding & Investors

PAX Labs is valued at $1.7B as of April 2019, a 15.0x multiple on its last reported $113M revenue.

Last PAX Labs valuation

$1.7B

Undisclosed stage · Apr 2019

Last PAX Labs funding round

$2B

Undisclosed stage · Nov 2023

PAX Labs revenue

$113M

Undisclosed stage · Apr 2019

Key investors in PAX Labs

  • Sand Hill Angels
  • Tiger Global
  • Fidelity
  • Evolution VC Partners
  • Tao Capital Partners
  • Arjun Sethi

PAX Labs Overview

About PAX Labs

PAX Labs is a San Francisco-headquartered designer of app-controlled vaporizers founded in 2007. The company produces portable devices like PAX 3 and PAX Mini for dry herb and concentrate consumption, featuring conduction heating, haptic feedback, and dynamic temperature control. PAX Labs focuses on cannabis accessories with lab-tested materials and Bluetooth connectivity for iOS and Android apps.


Founded

2007

HQ

United StatesSan Francisco, CA

Website

pax.com

Status

Privately held

Customer focus

B2C

Revenue model

Product sales

Revenue

$113M (Apr 2019)

Valuation

$1.7B (Apr 2019)

PAX Labs Valuation

PAX Labs is currently valued at $1.7B, based on its undisclosed-stage round in April 2019.

The $420M round was led by Tao Capital Partners and Tiger Global, with participation from Evolution VC Partners, Sand Hill Angels, ArmaVir Partners, Concrete Hill, IPD Capital and 2 other investors.

PAX Labs valuation by funding round

PAX Labs valuation by funding round
DateStageValuationRevenue Multiple
Apr 2019Undisclosed stage$1.7B15.0x

PAX Labs Revenue

PAX Labs' latest recorded revenue is $113M, as of its undisclosed-stage round in April 2019. At a $1.7B valuation, that implies a 15.0x revenue multiple.

PAX Labs revenue by funding round

PAX Labs revenue and valuation multiple by funding round
DateRevenue *ValuationRevenue MultipleStage
Apr 2019$113M$1.7B15.0xUndisclosed stage

* Revenue (or ARR) figures are the values recorded alongside each funding round. Typically run-rate revenue at the time of the deal, or a reported LTM (last 12 months) revenue.

PAX Labs Funding History

PAX Labs has raised a total of $2.5B across 4 funding rounds.

PAX Labs' first fundraising round was a $47M Series C in June 2015. The most recent completed round was a $2B undisclosed-stage round in November 2023.

PAX Labs funding rounds

PAX Labs funding rounds
DateStageInvestorsRaisedValuationDeal Summary
Nov 2023Undisclosed stage-$2B-PAX Labs, a San Francisco-based electronic vaporizer company known for cannabis vaporizers like PAX Era and PAX 3, raised a total of approximately $466.7 million across two main funding rounds. The most recent was a $420 million round in April 2019 led by Tiger Global Management, Tao Capital Partners, and Prescott General Partners, achieving a post-money valuation of $1.7 billion. The funds supported new product development, international expansion into markets like Canada, and exploration of hemp-based CBD extracts. The earlier round was $46.7 million in June 2015 led by Tao Capital and Sand Hill Angels, aimed at international expansion and product line growth. Investors include prominent firms like Tiger Global and the Pritzker family's Tao Capital.
Apr 2019Undisclosed stageTao Capital Partners (lead); Tiger Global (lead); Evolution VC Partners; Sand Hill Angels; ArmaVir Partners; Concrete Hill; IPD Capital; Irving Investors; Prescott General Partners$420M$1.7BPAX Labs is a San Francisco-based consumer technology company that designs and manufactures cannabis vaporizers. The company was founded in 2007 and developed a range of products including the PAX Era for concentrates and the PAX 3 for flower, alongside a mobile app that allows users to control temperature and draw strength. On April 22, 2019, PAX Labs confirmed the close of a $420 million Series E equity funding round at a post-money valuation of $1.7 billion. The round was led by existing investors Tiger Global Management and Tao Capital Partners, with new investors including Prescott General Partners and Redmile Group. According to TechCrunch, the company had initially targeted raising $150 million but exceeded that goal due to strong investor demand. The financing was designed to support new product development, expansion into international markets including Canada, exploration of hemp-based CBD extract opportunities, and significant hiring and brand growth initiatives. PAX Labs projected $113 million in revenue for 2019, with internal forecasts suggesting potential growth to approximately $1.2 billion by 2023. The company had previously spun out from Juul in 2017 and was backed by a roster of institutional investors spanning technology, healthcare, consumer products, and public equities sectors. The substantial funding round reflected investor confidence in the expanding cannabis legalization landscape and PAX's market positioning as a premium vaporizer brand focused on product innovation and consumer safety.
Oct 2018Undisclosed stageTao Capital Partners; Bracket Capital; Fidelity; Evolution VC Partners; Arjun Sethi; Sand Hill Angels; Tiger Global$26M-PAX Labs, a San Francisco-based maker of cannabis vaporizers including the PAX Era for concentrates and PAX 3 for flower, originated in 2007 and spun out from Juul in 2017 after developing the e-cigarette under the same umbrella. The company raised $20 million in October 2018, as described by CEO Bharat Vasan to Bloomberg as a deliberately small round, though prior backers included Tiger Global, Tao Capital, and Evolution VC Partners. This followed a June 2015 round of $46.7 million led by Tao Capital and Sand Hill Angels to expand internationally and grow products. A later April 2019 round raised $420 million at a confirmed post-money valuation of $1.7 billion, led by Tiger Global Management, Tao Capital Partners, and new investor Prescott General Partners, bringing total funding to about $466.7 million. Funds supported new products, international growth in markets like Canada, hemp-based CBD, hiring, and software enhancements for cannabis transparency amid legalization trends. Prior to that round, PAX eyed $400 million potentially valuing it at $1.3 billion, with a presentation citing $113 million revenue estimate for that year (likely 2019) and tenfold growth potential by 2023. The October 2018 $20 million round followed total prior funding of around $101.7 million up to mid-2018 per reports. PAX focuses on safe consumer access, regulatory compliance, and positioning as a leader in vaporizer hardware-software integration for cannabis.
Jun 2015Series CSand Hill Angels (lead); Tao Capital (lead); Sivia Capital; Fidelity$47M-PAX Labs, a San Francisco-based technology company, announced a Series C funding round of $46.7 million on June 10, 2015. The round was led by existing investors Tao Capital and Sand Hill Angels, with participation from Fidelity Management & Research Company, Sivia Capital, and other investors. The company planned to use the funding to expand internationally beyond the United States and Canada, deliver new products across additional verticals and categories, and accelerate growth of both its product line and customer base. At the time of the announcement, PAX Labs had recently unveiled the Juul tobacco-based vaporizer as a new product offering. The company was notable for having grown almost entirely organically through generated revenue, with this Series C round representing a significant external financing event after the company's previous funding in 2011. According to later-disclosed information, the April 2019 Series funding round valued the company at $1.7 billion.

Who has invested in PAX Labs?

14 investors have backed PAX Labs across its funding rounds, including Sand Hill Angels, Tiger Global, Fidelity, Evolution VC Partners, Tao Capital Partners and Arjun Sethi.

Lead investors include Tao Capital Partners, Tiger Global, Sand Hill Angels and Tao Capital.


PAX Labs Investors

Investors in PAX Labs by funding rounds participated
InvestorHQRoundsRoleFirst check
Sand Hill AngelsUnited StatesSan Francisco, CA3LeadJun 2015
Tao Capital PartnersUnited StatesSan Francisco, CA2LeadOct 2018
FidelityUnited StatesBoston, MA2ParticipantJun 2015
Evolution VC PartnersUnited StatesNew York City, NY2ParticipantOct 2018
Tiger GlobalUnited StatesNew York City, NY2LeadOct 2018
Bracket CapitalUnited StatesLos Angeles, CA1ParticipantOct 2018
Sivia CapitalUnited StatesSan Francisco, CA1ParticipantJun 2015
Arjun SethiUnited StatesSan Francisco, CA1ParticipantOct 2018
Tao CapitalChinaBeijing1LeadJun 2015
ArmaVir PartnersUnited StatesNew York City, NY1ParticipantApr 2019
Concrete HillUnited StatesLos Angeles, CA1ParticipantApr 2019
IPD CapitalUnited StatesMiami, FL1ParticipantApr 2019

This data is available for Pro users. Sign up to see all 14 PAX Labs investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

PAX Labs Competitors

PAX Labs competitors include listed companies like Green Thumb Industries, Trulieve Cannabis, Cronos Group and Curaleaf, and private ones like Accelerant and Dutchie.

Public and private companies comparable to PAX Labs
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
Green Thumb IndustriesUnited StatesUnited StatesPublicly listed$1.2B$469M$1.6B1.6x
Trulieve CannabisUnited StatesUnited StatesPublicly listed$1.2B$314M$2.2B2.4x
Cronos GroupCanadaCanadaPublicly listed$147M($43M)$1.2B2.6x
AccelerantUnited StatesBaltimore, MDPrivate$913M$282M$2.4B2.6x
CuraleafUnited StatesUnited StatesPublicly listed$1.3B$238M$2.7B2.7x
DutchieUnited StatesBend, ORPrivate$45M-$3.8B83.3x

PAX Labs Public Comps

PAX Labs is still privately-owned, but its public comps include Green Thumb Industries, Cronos Group, Trulieve Cannabis, Glass House Brands, Curaleaf, Vireo Growth, Tilray Brands, Verano Holdings, Canopy Growth and SNDL.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Green Thumb Industries$1.2B$469M1.6x1.6x4.0x5.9x
Cronos Group$147M($43M)3.3x2.6x(11.3x)20.3x
Trulieve Cannabis$1.2B$314M2.1x2.4x7.9x6.7x
Glass House Brands$182M$6M4.9x4.6x162.4x36.6x
Curaleaf$1.3B$238M2.8x2.7x14.9x12.6x
Vireo Growth$269M$12M3.7x1.6x81.7x7.4x
Tilray Brands$915M$3M0.8x0.7x218.8x10.7x
Verano Holdings$822M$24M1.0x1.0x36.4x4.0x

This data is available for Pro users. Sign up to see all PAX Labs competitors and their valuation data.

Start Free Trial

Common questions about PAX Labs

When was PAX Labs founded?PAX Labs was founded in 2007.
Where is PAX Labs headquartered?PAX Labs is headquartered in San Francisco, CA, United States.
Is PAX Labs publicly listed?No, PAX Labs is a private, VC-backed company.
What is PAX Labs' valuation?PAX Labs was last valued at $1.7B in its undisclosed-stage round in April 2019.
How much funding has PAX Labs raised?PAX Labs has raised $2.5B across 4 funding rounds.
What was PAX Labs' last funding round?PAX Labs' last funding round was a $2B undisclosed-stage round in November 2023.
Who are PAX Labs' investors?PAX Labs' investors include Sand Hill Angels, Tao Capital Partners, Fidelity, Evolution VC Partners, Tiger Global, Bracket Capital, Sivia Capital, Arjun Sethi, Tao Capital, ArmaVir Partners and 4 others.
What is PAX Labs' revenue?PAX Labs' latest recorded revenue is $113M (April 2019).
What is PAX Labs' revenue multiple?PAX Labs' latest valuation implies a 15.0x revenue multiple ($1.7B valuation on $113M of revenue).
Which companies are comparable to PAX Labs?Companies comparable to PAX Labs include Green Thumb Industries, Trulieve Cannabis, Cronos Group, Accelerant, Curaleaf and Dutchie.

See companies similar to PAX Labs

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial